Dopamine receptor 3(DRD3) polymorphism and risk for migraine

European Journal of Neurology

Volumn 17, Issue 9, 2010, Pages 1220-1223

  Garcia Martin E ^a   Martinez C ^a   Serrador, M ^b   Alonso Navarro, H ^b,c   Navacerrada, F ^b,d   Agundez J A G ^a   Jimenez Jimenez F J ^b,d  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^d Hospital Universitario del Sureste de Madrid   (Spain)

Author keywords

dopamine; dopamine receptor D3; genetic polymorphisms; migraine; risk factors

Indexed keywords

ALCOHOL; DOPAMINE 3 RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE AURA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; CENTRAL NERVOUS SYSTEM DEPRESSANTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D3; RISK FACTORS; SPAIN;

EID: 77955794039     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.02988.x     Document Type: Article

References (14)

1. Mateos V, Pareja JA, Pascual J. Tratado de cefaleas (ISBN 978-84-7989-535-9).
2. Akerman S, Goadsby PJ. Dopamine and migraine:biology and clinical implications. Cephalalgia 2007 27 : 1308 1314.
3. Fanciullacci M, Alessandri M, Del Rosso A. Dopamine involvement in the migraine attack. Funct Neurol 2000 15 (Suppl 3 171 181.
4. D'Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G. Platelet levels of dopamine are increased in migraine and cluster headache. Headache 2006 46 : 585 591.
5. Shukla R, Khanna VK, Vinod P, Sankhwar ML, Yadav RS. Platelet dopamine:D2 receptor binding in patients with migraine. Cephalalgia 2009 29 : 532 538.
6. Barbanti P, Fabbrini G, Ricci A, et al. Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 2000 20 : 15 19.
7. Shepherd AG, Lea RA, Hutchins C, Jordan KL, Brimage PJ, Griffiths LR. Dopamine receptor genes and migraine with and without aura: an association study. Headache 2002 42 : 346 351.
8. Del Zompo M, Cherchi A, Palmas MA, et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998 51 : 781 786.
9. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor(DRD2) NcoI alleles. Mol Med 1998 4 : 14 21.
10. Todt U, Netzer C, Toliat M, et al. New genetic evidence for involvement of the dopamine system in migraine with aura. Hum Genet 2009 125 : 265 279.
11. Mochi M, Cevoli S, Cortelli P, et al. A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta- hydroxylase genes. Neurol Sci 2003 23 : 301 305.
12. De Sousa SC, Karwautz A, Wober C, et al. A dopamine D4 receptor exon 3 VNTR allele protecting against migraine without aura. Ann Neurol 2007 61 : 574 578.
13. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004 24 (Suppl 1) : 1 160.
14. Vitale C, Gulli R, Ciotti P, et al. DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients. Eur J Neurol 2008 15 : 985 987.